Condition
Menstrual Bleeding, Heavy
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07457957Not ApplicableNot Yet Recruiting
Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents
NCT05856838Not ApplicableRecruitingPrimary
NovaSure Study: Endometrial Ablation in Women With Heavy Menstrual Bleeding
NCT07084714Not ApplicableRecruiting
Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms
NCT06689150Not ApplicableCompletedPrimary
Evaluation of the Contraceptive Efficacy
NCT05862805Phase 1RecruitingPrimary
PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
Showing all 5 trials